Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imiquimod in CIN 2/3
NCT00941252Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2009
- Primary completion
- Jan 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cervical intraepithelial neoplasia (CIN) comparing Imiquimod with Placebo (2 arms). Primary endpoint: Efficacy of topical treatment with Imiquimod. Started Jul 2009; status: completed.
02
Drugs
imiquimod
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00941252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941252.